SAMANTHA MCLAREN: Open Payments
NPI 1346837564 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,685 in 73 payments from 11 companies in 2025. Trend: 2023 $1,566 · 2024 $1,148 · 2025 $1,685
Food & beverage: $1,485Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $473 |
| SK Life Science, Inc. | 12 | $309 |
| UCB, Inc. | 13 | $255 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $200 |
| SI-BONE, INC. | 1 | $133 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $73 |
| HARMONY BIOSCIENCES LLC | 1 | $46 |
| Lilly USA, LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: QULIPTA, LUMRYZ, UBRELVY, Nayzilam, Qelbree, Briviact, BOTOX, VYVGART.
Industry payments across FL — which companies pay providers there.
